MASON, Andrew L

5 enregistrements totalisant 2,554,348.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.

Intégrer ce graphique

Par ministère

Enregistrements

MASON, Andrew L $768,058.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2014-2015
Canada

Translational studies to test potential therapies for patients with primary biliary cirrhosis

Mason, Andrew L $703,800.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2018-2019
Canada

Pilot study of emtricitabine, tenofovir alafenamide and raltegravir for patients with primary biliary cholangitis

MASON, Andrew L $506,269.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2011-2012
Canada

Pilot study of highly active anti-retroviral therapy for patients with primary biliary cirrhosis

MASON, Andrew L $426,221.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2011-2012
Canada

Isolation of a novel human retrovirus associated with primary biliary cirrhosis and fulfillment of koch's postulates in vitro

Mason, Andrew L $150,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
EF 2020-2021
Canada

The specific objective of this funding opportunity is: To harness the power of new technologies and interventions to prevent the onset of cancer and/or reduce its severity though early detection wh...